Telehealth and direct-to-consumer (DTC) prescription models have expanded rapidly in recent years, driven by pandemic-era adoption, consumer demand for convenience, and increasing involvement from pharmaceutical manufacturers. Telehealth platforms now frequently integrate virtual consultations, e-prescribing, and home delivery into a single digital pathway, allowing patients to obtain medications without visiting a traditional pharmacy counter. At the same time, drug manufacturers and digital health companies are building DTC ecosystems that connect patients directly to prescribing providers and dispensing channels, often emphasizing cash-pay pricing transparency and faster access to therapy. This shift is contributing to the “consumerization” of healthcare, with millions of users engaging telehealth platforms for conditions ranging from chronic disease to lifestyle therapies.

These trends are reshaping traditional pharmacy dispensing by bypassing or disintermediating brick-and-mortar pharmacies in some cases, reducing prescription volume and limiting opportunities for pharmacist-led medication management. DTC and telehealth models can fragment care by separating prescribing from dispensing and from longitudinal patient oversight, potentially weakening the pharmacist’s role in counseling, adherence monitoring, and safety checks. At the same time, they introduce competitive pressure on pricing and convenience, accelerating home delivery and digital pharmacy services while contributing to retail pharmacy consolidation and store closures.

The April 2026 poll results indicate that the primary concern surrounding telehealth and direct-to-consumer prescription models is the fragmentation of patient records, cited by 43% of respondents, suggesting apprehension about gaps in care coordination and incomplete medication histories. Medication safety risk was the next most common concern at 36%, reflecting worries about reduced oversight in prescribing and dispensing processes. Fewer respondents identified reduced face-to-face counseling (14%) as their top issue, while only 7% pointed to the potential for increased misuse.

As telehealth and direct-to-consumer prescription trends grow (ex: TrumpRx style model), what concerns you most about their effect on traditional pharmacy dispensing?

Reduced face-to-face counseling: 14%

Medication safety risk: 36%

Fragmentation of patient records: 43%

Potential for increased misuse: 7%

Minimal/No concern: 0%